Excelsior Correspondent
SOLAN, June 27: Dr Deepak Kumar, Professor at the School of Pharmaceutical Sciences, Shoolini University, has earned international recognition with the publication of his cancer research in the prestigious journal Nature Signal Transduction and Targeted Therapy, which has an impressive Impact Factor of 52.7.
A statement said Dr Kumar’s study focuses on the mTOR signalling pathway, which plays a key role in cancer growth, aging, immunity, and metabolism.
His findings suggest that targeting this pathway could help slow cancer and combat age-related diseases like neurological disorders and diabetes, it said.
The statement further said that the research has already received over 466 citations, underlining its global impact.
Speaking about the breakthrough, Dr Kumar said, “Our aim was to better understand how the mTOR pathway works and how it can be targeted to treat cancer and other chronic diseases.”
“The study shows that by controlling mTOR activity, we may be able to not only slow down cancer, but also fight age-related diseases like neurological disorders and diabetes,” he said.
Chancellor of Shoolini University, Prof P K Khosla, praised the achievement, saying it brings pride to the university and showcases its commitment to impactful scientific research.
Follow our WhatsApp channel
